Meetings:

Federal Register Volume 76, Number 162 (Monday, August 22, 2011)

Notices

Page 52334

From the Federal Register Online via the Government Printing Office [www.gpo.gov]

FR Doc No: 2011-21380

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

Docket No. FDA-2011-N-0002

Arthritis Advisory Committee; Notice of Postponement of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

SUMMARY: The Food and Drug Administration (FDA) is postponing the

Arthritis Advisory Committee meeting scheduled for September 13, 2011.

This meeting was announced in the Federal Register of July 19, 2011 (76

FR 42715). The postponement is due to the fact that the Agency recently received submissions from some of the investigational new drug (IND) application holders for anti-nerve growth factor (Anti-NGF) antibody drug products that contain large quantities of new information that will require additional time for Agency review prior to the advisory committee meeting.

FOR FURTHER INFORMATION CONTACT: Philip A. Bautista, Center for Drug

Evaluation and Research, Food and Drug Administration, 10903 New

Hampshire Ave., Bldg. 31, rm. 2417, Silver Spring, MD 20993-0002, 301- 796-9001, FAX 301-827-8533, e-mail: AAC@fda.hhs.gov, or FDA Advisory

Committee Information Line, 1-800-741-8138 (301-443-0572 in the

Washington, DC area), and follow the prompts to the desired center or product area. Please call the Information Line for up-to-date information on this meeting.

Dated: August 17, 2011.

Leslie Kux,

Acting Assistant Commissioner for Policy.

FR Doc. 2011-21380 Filed 8-19-11; 8:45 am

BILLING CODE 4160-01-P